On Tuesday, Anavex Life Sciences Corporation (NASDAQ: AVXL) opened lower -1.04% from the last session, before settling in for the closing price of $9.13. Price fluctuations for AVXL have ranged from $3.25 to $10.45 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 9.44% at the time writing. With a float of $82.10 million, this company’s outstanding shares have now reached $84.80 million.
Let’s determine the extent of company efficiency that accounts for 40 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Anavex Life Sciences Corporation (AVXL) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Anavex Life Sciences Corporation is 3.18%, while institutional ownership is 31.82%. The most recent insider transaction that took place on Jun 14 ’24, was worth 10,319. In this transaction Director of this company bought 2,835 shares at a rate of $3.64, taking the stock ownership to the 5,000 shares. Before that another transaction happened on May 15 ’24, when Company’s Director bought 5,000 for $4.52, making the entire transaction worth $22,600. This insider now owns 5,000 shares in total.
Anavex Life Sciences Corporation (AVXL) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.12 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.15) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.44% per share during the next fiscal year.
Anavex Life Sciences Corporation (NASDAQ: AVXL) Trading Performance Indicators
Check out the current performance indicators for Anavex Life Sciences Corporation (AVXL). In the past quarter, the stock posted a quick ratio of 12.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.50, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.63 in one year’s time.
Technical Analysis of Anavex Life Sciences Corporation (AVXL)
Looking closely at Anavex Life Sciences Corporation (NASDAQ: AVXL), its last 5-days average volume was 1.76 million, which is a jump from its year-to-date volume of 1.21 million. As of the previous 9 days, the stock’s Stochastic %D was 71.06%. Additionally, its Average True Range was 0.77.
During the past 100 days, Anavex Life Sciences Corporation’s (AVXL) raw stochastic average was set at 76.46%, which indicates a significant increase from 56.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 109.50% in the past 14 days, which was higher than the 79.89% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.54, while its 200-day Moving Average is $5.33. However, in the short run, Anavex Life Sciences Corporation’s stock first resistance to watch stands at $10.03. Second resistance stands at $11.02. The third major resistance level sits at $11.69. If the price goes on to break the first support level at $8.37, it is likely to go to the next support level at $7.70. Now, if the price goes above the second support level, the third support stands at $6.71.
Anavex Life Sciences Corporation (NASDAQ: AVXL) Key Stats
There are currently 84,796K shares outstanding in the company with a market cap of 766.13 million. Presently, the company’s annual sales total 0 K according to its annual income of -47,510 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -12,210 K.
